In this series, Digital Health Business & Technology will interview a range of digital health investors, from those who work at venture capital and private equity firms and at health system and health insurance venture funds, to individual and angel investors. If you’re interested in participating in this series, email us here.
When Dr. Zack Scott was going through medical school, he didn’t originally envision a professional trajectory that would lead him away from clinical care.
“But once you start to practice medicine, you realize that despite all of our advancements, the delivery of care is not as good as it should be,” Scott said.
During his medical training, Scott got a chance to interact with Dr. Julio Palmaz, who invented one of the first cardiac stents to prevent heart attacks. Meeting Palmaz and learning about the power of health innovation, along with Scott's family history of entrepreneurship, inspired him to get his MBA after residency and pursue a venture capital career path.
In September 2022, he became general partner at San Francisco-based Norwest Venture Partners, which invests in digital health, biotech and medtech companies.
Scott spoke about the importance of clinical evidence when it comes to investing in digital health companies, the potential role real-world data can play in clinical trials and more. The interview has been edited for length and clarity.